Continuation of afatinib beyond progression: Results of a randomized, open-label, phase III trial of afatinib plus paclitaxel (P) versus investigator’s choice chemotherapy (CT) in patients (pts) with metastatic non-small cell lung cancer (NSCLC) progressed on erlotinib/gefitinib (E/G) and afatinib—LUX-Lung 5 (LL5).
Martin H. Schuler
Research Funding - Boehringer Ingelheim
Chih-Hsin Yang
Consultant or Advisory Role - AstraZeneca; Boehringer Ingelheim; Clovis; Genentech; InnoPharma ; Lilly; Merck Serono; Novartis; Pfizer; Roche; Takeda
Honoraria - Abbott Laboratories; AstraZeneca; Bayer; Boehringer Ingelheim; Pfizer; Roche
Research Funding - Boehringer Ingelheim
Keunchil Park
Consultant or Advisory Role - Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Clovis; Lilly; Roche
Research Funding - AstraZeneca
Jaafar Bennouna
Consultant or Advisory Role - Boehringer Ingelheim
Honoraria - Boehringer Ingelheim
Yuh-Min Chen
Honoraria - AstraZeneca; Lilly; Roche
Christos Chouaid
Honoraria - Boehringer Ingelheim
Filippo De Marinis
No relevant relationships to disclose
Ji Feng Feng
No relevant relationships to disclose
Francesco Grossi
No relevant relationships to disclose
Dong-Wan Kim
No relevant relationships to disclose
Xiaoqing Liu
No relevant relationships to disclose
Shun Lu
Consultant or Advisory Role - AstraZeneca (U); Boehringer Ingelheim (U)
Janos Strausz
No relevant relationships to disclose
Yurii Vinnyk
Research Funding - Boehringer Ingelheim
Rainer Wiewrodt
Consultant or Advisory Role - Boehringer Ingelheim; Grifols; Lilly; Novartis; Roche
Honoraria - Bayer; Boehringer Ingelheim; GlaxoSmithKline; Grifols; Lilly; MSD; Pfizer; Roche
Research Funding - Bayer; Boehringer Ingelheim; GlaxoSmithKline; Lilly; Novartis; Roche
Caicun Zhou
Consultant or Advisory Role - Boehringer Ingelheim; Clovis; Lilly; Roche
Vikram K. Chand
Employment or Leadership Position - Boehringer Ingelheim
Bushi Wang
Employment or Leadership Position - Boehringer Ingelheim
Joo-Hang Kim
Research Funding - Boehringer Ingelheim; Lilly; Pfizer; SoIT by Roche
David Planchard
Consultant or Advisory Role - Boehringer Ingelheim